My Short Biography:
Director, Center for Metabolic Disease Research，Associate Dean for Research，Laura H. Carnell Professor, Pharmacology，Temple University School of Medicine
Dr. Hong Wang received her medical training from JinagXi Medical School, an MS degree from Peking Union Medical University, a PhD degree in Biochemistry from University of Montreal, and an EMBA degree from Fox Business School in Temple University. She did her post-doctoral fellowship and then was a research associate in Harvard School of Public Health from 1996 to 1999. She joined faculty in Baylor College of Medicine as an assistant professor in 1999. She moved to Temple University School of Medicine as an associate professor in 2005, and became a tenured professor in 2007.
Dr. Wang currently is a Pharmacology Professor and Director for the Center for Metabolic Disease Research. She teaches Pharmacology in TUSM, Podiatry School of Medicine, School of Dentistry and Temple University Graduate School. Her research focuses are cardiovascular inflammation, atherosclerosis, vascular function, molecular mechanism, and signal transduction. She is an editorial member of JCI, Circulation, ATVB, J Molecular & Cellular Cardiology and Clinical Medicine: Pathology. She is Editor-in-Chief of Biomarker Research.
Dr. Wang’s research focuses on identifying biochemical mechanisms responsible for hyperhomocysteinemia (HHcy) –induced cardiovascular disease, and discovering therapeutic targets and novel therapeutic strategies. She is a leading scientist in this field and has made significant contribution to the field, including 1) established the causative role of HHcy in atherosclerosis, 2) systemically investigated the role and mechanism of HHcy on vascular pathology, HDL metabolism and inflammatory monocyte differentiation, and 3) established hypomethylation as a key biochemical mechanism for selective endothelium injury in hyperhomocysteinemia.
This website is optimized for Chrome and Internet Explorer 11.